Florida Cancer Specialists Press Release

Dr. Craig Reynolds Joins Florida Cancer Specialists & Research Institute

Nation’s Largest Independent Oncology Group Adds New Physician in Marion County

Ocala, FL – October 11, 2016……… Florida Cancer Specialists & Research Institute (FCS)), the leading community oncology/hematology practice in the state, is pleased to announce that Craig Reynolds, MD, has joined the practice and is seeing patients at the Ocala office of Florida Cancer Specialists, located at 1630 SE 18th Street – Suite 602, Ocala, FL.

FCS CEO Bradley Prechtl said, “FCS opened the Ocala office in June of 2014 and since that time, the practice has been growing rapidly. Dr. Reynolds has been a leading oncologist in Marion County for over two decades and has an excellent reputation. He will bring added convenience for our patients in the Ocala community and we are extremely pleased to have him join the FCS family.”

Dr. William Harwin, Founder and President of FCS, added, “We are delighted to welcome Dr. Reynolds to Florida Cancer Specialists. He is a highly dedicated physician and is widely recognized for his clinical research. Dr. Reynolds also provides physician leadership with several organizations, including serving on the Education Committee for the American Society of Clinical Oncology (ASCO). I know he will be a great addition to our practice in Marion County.”

Craig Reynolds, MD
Medical Oncologist

While completing his Fellowship in Oncology/Hematology, Dr. Craig Reynolds also worked as an instructor in Medicine and Hematology/Oncology at Washington University School of Medicine and as a staff physician at John Cochran VA Hospital in St. Louis, MO. In 1993, he moved to Ocala, FL and began his practice at the Ocala Oncology Center, where he later served as Director of Research from 2008 to 2014. During his distinguished career, Dr. Reynolds has been recognized with numerous awards and acknowledgments and has provided physician leadership on various committees and advisory boards; he currently serves on the Education Committee of the American Society of Clinical Oncology (ASCO), the Community Practice Committee of the International Association for the Study of Lung Cancer and the Thoracic Oncology Workgroup of Ocala Regional Medical Center, where he is also a faculty member for house staff training programs. A recognized leader in clinical research, Dr. Reynolds has been an invited speaker at several national and international conferences and his research has been extensively published in such prestigious journals as Blood, Cancer, Journal of Clinical Oncology and Journal of Thoracic Oncology.

Dr. Patrick Acevedo, who opened the FCS office in Ocala, said, “As a community oncology practice, we have an ongoing commitment to our patients to provide the most advanced and personalized treatments in a setting that is convenient and close to where our patients live. With a recent expansion of our office and now with the addition of Dr. Reynolds, we will be able to better serve patients and their families in Ocala and surrounding communities.”

Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.


About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 150 nurse practitioners and physician assistants and over 90 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 70% of new cancer drugs approved in 2015 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast in Daytona/Palm Coast, Vero Beach/Sebastian and in Palm Beach County.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

* Prior to approval

For More Information, Contact:
Florida Cancer Specialists Foundation & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer -

Chappell Roberts
Chris Wilkerson -
813.281.0088 ext. 315

Ganick Communications, Inc.
Elaine Ganick -